glp 1 agonist diabetes GLP-1 Receptor Agonists as Treatments for Type 2 GLP1-GIP receptor co-agonists: a promising

Harper, who in 1943 helped to establish that the gastro-intestinal hormone pancreozymin stimulated the secretion of pancreatic enzymes (Kieffer

This piece in 1993 also provided new insights into the biology of exendin, namely that exendin-4 was a full agonist of the human GLP-1 receptor, which Mojsov argues was crucial to convincing Amylin to develop exendin as a drug for diabetes (see below)

The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents

Traditional approaches to obesity management, including lifestyle interventions and older pharmacotherapies, have historically demonstrated limited long-term efficacy, creating an urgent need for more effective therapeutic options